Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−1.120EUR
−28.34 MEUR
−3.62 MEUR
19.19 M
About VIVORYON THERAPEUTICS N.V. NPV
Sector
Industry
CEO
Frank T. Weber
Website
Headquarters
Halle
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG00JHW6J47
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0R3M is 0.820 EUR — it has decreased by 4.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VIVORYON THERAPEUTICS N.V. NPV stocks are traded under the ticker 0R3M.
VIVORYON THERAPEUTICS N.V. NPV is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
0R3M stock is 14.40% volatile and has beta coefficient of 1.45. Check out the list of the most volatile stocks — is VIVORYON THERAPEUTICS N.V. NPV there?
Yes, you can track VIVORYON THERAPEUTICS N.V. NPV financials in yearly and quarterly reports right on TradingView.
0R3M stock has risen by 68.71% compared to the previous week, the month change is a 51.84% rise, over the last year VIVORYON THERAPEUTICS N.V. NPV has showed a 93.94% decrease.
0R3M net income for the last quarter is −17.63 M EUR, while the quarter before that showed −10.72 M EUR of net income which accounts for −64.48% change. Track more VIVORYON THERAPEUTICS N.V. NPV financial stats to get the full picture.
Today VIVORYON THERAPEUTICS N.V. NPV has the market capitalization of 23.17 M, it has increased by 20.38% over the last week.
No, 0R3M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0R3M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS N.V. NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIVORYON THERAPEUTICS N.V. NPV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIVORYON THERAPEUTICS N.V. NPV stock shows the sell signal. See more of VIVORYON THERAPEUTICS N.V. NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VIVORYON THERAPEUTICS N.V. NPV future price: according to them, 0R3M price has a max estimate of 64.00 EUR and a min estimate of 0.70 EUR. Read a more detailed VIVORYON THERAPEUTICS N.V. NPV forecast: see what analysts think of VIVORYON THERAPEUTICS N.V. NPV and suggest that you do with its stocks.